Elizabeth Garrett-Mayer
Overview
Explore the profile of Elizabeth Garrett-Mayer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
7819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cottrell T, Lotze M, Ali A, Bifulco C, Capitini C, Chow L, et al.
J Immunother Cancer
. 2025 Mar;
13(3).
PMID: 40054999
Immunotherapy of cancer is now an essential pillar of treatment for patients with many individual tumor types. Novel immune targets and technical advances are driving a rapid exploration of new...
2.
Winer E, Levit L, Basch E, Chavez-MacGregor M, Dubois R, Eckhardt S, et al.
J Clin Oncol
. 2025 Feb;
:JCO2402246.
PMID: 39928904
In this statement, ASCO encourages academic medical centers to change their policies and expectations to enhance and promote the professional fulfillment of academic medical oncologists. The statement includes three recommendations...
3.
Schenkel C, Levit L, Kirkwood K, Spence R, Burke J, Gallagher C, et al.
JCO Oncol Adv
. 2025 Feb;
2(1):e2400010.
PMID: 39906334
Purpose: Recent data suggest that the rate of burnout among oncologists has risen over time. In addition to the negative effect of burnout on individuals, widespread burnout may prevent the...
4.
Ursino M, Villacampa G, Rekowski J, Dimairo M, Solovyeva O, Ashby D, et al.
EClinicalMedicine
. 2025 Jan;
79:102988.
PMID: 39877554
Funding: This work is a further extension of the SPIRIT-DEFINE study, which obtained no external funding. The principal investigator (CY) used internal staff resources, together with additional resources from external...
5.
Rekowski J, Guo C, Solovyeva O, Dimairo M, Rouhifard M, Patel D, et al.
EClinicalMedicine
. 2025 Jan;
79:102987.
PMID: 39877553
Funding: This work is a further extension of the CONSORT-DEFINE study, which was funded by the UK Medical Research Council (MRC)-National Institute for Health and Care Research (NIHR) Methodology Research...
6.
Worden F, Pisick E, Rothe M, Mangat P, Garrett-Mayer E, Khalil M, et al.
JCO Precis Oncol
. 2024 Oct;
8:e2400477.
PMID: 39413339
Purpose: Targeted Agent and Profiling Utilization Registry is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and targetable genomic...
7.
Caswell-Jin J, Freedman R, Hassett M, Tang H, Garrett-Mayer E, Somerfield M, et al.
JCO Oncol Pract
. 2024 Sep;
21(3):287-291.
PMID: 39303175
No abstract available.
8.
McKelvey B, Garrett-Mayer E, Rivera D, Alabaster A, Andrews H, Bond E, et al.
JCO Clin Cancer Inform
. 2024 Aug;
8:e2400091.
PMID: 39146509
Purpose: Real-world data (RWD) holds promise for ascribing a real-world (rw) outcome to a drug intervention; however, ascertaining rw-response to treatment from RWD can be challenging. Friends of Cancer Research...
9.
Schuetze S, Rothe M, Mangat P, Garrett-Mayer E, Meric-Bernstam F, Calfa C, et al.
JCO Precis Oncol
. 2024 Jul;
8:e2400219.
PMID: 39013131
Purpose: Targeted Agent and Profiling Utilization Registry (TAPUR) is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and genomic...
10.
Srkalovic G, Rothe M, Mangat P, Garrett-Mayer E, Ahn E, Brouse G, et al.
JCO Precis Oncol
. 2024 Jun;
8:e2400026.
PMID: 38865672
Purpose: The Targeted Agent and Profiling Utilization Registry Study is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and...